Clinical Case Reports (May 2024)

Hereditary epidermolytic palmoplantar keratosis due to a novel desmoglein‐1 mutation: A case report

  • Kevin Koschitzki,
  • Bernadett Kurz,
  • Julia Schreml,
  • Judith Fischer,
  • Alrun Hotz,
  • Christoph M. Hammers,
  • Mark Berneburg,
  • Dennis Niebel,
  • Stephan Schreml

DOI
https://doi.org/10.1002/ccr3.8881
Journal volume & issue
Vol. 12, no. 5
pp. n/a – n/a

Abstract

Read online

Key Clinical Message Keratosis palmoplantaris striata type I (SPPK‐I) is a rare autosomal‐dominant type of hereditary epidermolytic palmoplantar keratoderma, which can be caused by mutations in desmoglein‐1 (DSG‐1). Patients suffer from hyperkeratotic plaques and painful palmoplantar fissures. Unfortunately, treatment options including salicylic vaseline, topical corticosteroids, phototherapy, and retinoids are inefficient. Abstract Hereditary palmoplantar keratodermas (PPKs) represent a heterogeneous group of rare skin disorders with epidermal palmoplantar hyperkeratosis. Mutations in the desmoglein 1 gene (DSG1), a transmembrane glycoprotein, have been reported primarily in striate PPKs. We report a patient with keratosis palmoplantaris striata type I (SPPK‐I) with a specific pathogenic variant [c.349C>T, p.(Arg117*)] in DSG1. Despite increased understanding, effective treatment options for PPK, including SPPK‐I, remain limited.

Keywords